New Launch of 'Lulu Direct S Tablets' <Launch Date: August 31, 2026 (Mon)>

Daiichi Sankyo Healthcare Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President: Hirohiro Uchida; hereinafter 'the Company') announces the launch of 'Lulu Direct S Tablets' (OTC medicine: Designated Category II) on Monday, August 31, 2026. This new antitussive and expectorant medication is developed under the long-selling cold remedy brand 'Lulu,' specifically targeting severe cough and phlegm symptoms with enhanced efficacy.

Cough and phlegm are symptoms that can significantly impact daily life, whether during the day or at bedtime. With this launch, the Company introduces 'Lulu Direct S Tablets' as a new addition to the 'Lulu' brand lineup, specially formulated to address the most troublesome cough and phlegm symptoms associated with colds.

Through the 'Lulu' brand, the Company will continue to support the health of individuals and contribute to improving their quality of life (QOL).

1. Product Features

◎ A tablet-form antitussive and expectorant that combines five active ingredients—four targeting cough (※1) and one targeting phlegm (※2)—to effectively relieve severe, persistent cough and phlegm.

◎ Non-caffeinated formula that does not interfere with sleep.

◎ Packaged in a PTP sheet format, allowing users to carry only the required dosage when外出, making it convenient for on-the-go use.

2. About the 'Lulu' Brand

The tablet-form cold medicine 'Lulu' was first launched in 1951.

At a time when compounding medicines at pharmacies was standard practice, 'Lulu' stood out by combining multiple active ingredients to address various cold symptoms and coating them with sugar to create an easy-to-take tablet. With its iconic slogan 'Sneeze three times? Take three Lulu tablets,' it became widely recognized as a household staple medicine.

'Lulu' has been loved by generations of customers. To remain a trusted health companion for families, the brand continuously expands and improves its product lineup in response to evolving lifestyles and living environments, contributing to enhanced quality of life (QOL).

First-generation 'Lulu' (Launched February 1951)

Lulu Brand Website

<Reference>

About Daiichi Sankyo Healthcare

Daiichi Sankyo Healthcare is building on its strengths as a leading company in the OTC pharmaceutical sector, expanding its business into functional skincare, oral care, and food products. As a total healthcare company, it continues to grow by supporting people's healthy lives.

The company's corporate slogan, 'Fit for You – A Life Partner for Everyone’s Healthy Living,' reflects its mission to contribute to a society where everyone can confidently practice self-care and self-medication.

※1 Dihydrocodeine phosphate, Noscapine, dl-Methylephedrine hydrochloride, Chlorpheniramine maleate

※2 L-Carbocisteine

<Press Release (PDF)>

https://www.daiichisankyo-hc.co.jp/content/000142273.pdf